Cargando…
Dual versus mono antiplatelet therapy for acute non-cardioembolic ischaemic stroke or transient ischaemic attack: a systematic review and meta-analysis
OBJECTIVE: Recent years have seen new evidence on the efficacy and safety of dual antiplatelet therapy for secondary stroke prevention. We updated a meta-analysis of randomised controlled trials evaluating dual antiplatelet versus monotherapy for patients with acute non-cardioembolic ischaemic strok...
Autores principales: | Yang, Yingying, Zhou, Mengyuan, Zhong, Xi, Wang, Yongjun, Zhao, Xingquan, Liu, Liping, Wang, Yilong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047341/ https://www.ncbi.nlm.nih.gov/pubmed/30022798 http://dx.doi.org/10.1136/svn-2018-000168 |
Ejemplares similares
-
Acute dual antiplatelet therapy for minor ischaemic stroke or transient ischaemic attack
por: Wang, Yongjun, et al.
Publicado: (2019) -
Low serum albumin levels predict poor outcome in patients with acute ischaemic stroke or transient ischaemic attack
por: Zhou, Hongyu, et al.
Publicado: (2021) -
Refining prediction of major bleeding on antiplatelet treatment after transient ischaemic attack or ischaemic stroke
por: Hilkens, Nina A, et al.
Publicado: (2020) -
Concurrent intracranial and extracranial artery stenosis and the prognosis of transient ischaemic symptoms or imaging-negative ischaemic stroke
por: Suo, Yue, et al.
Publicado: (2020) -
Secondary prevention medication persistence and prognosis of acute ischaemic stroke or transient ischaemic attack
por: Zhang, Lei, et al.
Publicado: (2021)